|
|
Effects of Low-dose l-t4 on Biochemical Markers of Benign Small Nodules and Its Influencing Factors |
WANG Shangnong, et al |
Beijing Sixth Hospital, Beijing 100007, China |
|
|
Abstract Objective: To investigate the effect of low-dose l-t4 on the biochemical markers of benign small nodules and the influencing factors. Methods: From January 2016 to January 2018, 78 patients with benign thyroid nodules were enrolled in the endocrinology department of our hospital. They were divided into observation group and control group according to the random number table method. Small doses were taken for the observation group. Left thyroid hormone (l-t4) treatment, the course of treatment is 1 year, no drug treatment for the control group, only clinical observation and follow-up. TSH, JV, JD3, small nodule diameter and thyroid-stimulating hormone levels and serum free thyroxine (FT4) were measured every 3 months. The detection is performed in 4 cycles horizontally. At the same time, a total study of 39 patients in the observation group was conducted to investigate the effect of gender and age on the diameter of small thyroid nodules in patients. Results: After 12 months of treatment, the thyroid volume (8.52±8.68) cm3 and the maximum nodule cross-section diameter (47.88±8.54) mm in the observation group were significantly smaller than those in the control group (13.16±9.88) cm3 and (63.48±10.24) mm, and the difference was statistically significant (P<0.05). After 12 months, the diameter of small nodules in the observation group (4.84±1.80) mm was significantly lower than that in the control group (6.33±1.91) mm, and the difference was statistically significant (P<0.05). After 12 months of treatment, the level of thyrotropic hormone (0.36±0.14) mIU/L in the observation group was significantly lower than that in the control group (1.86±0.78) mIU/L, and serum free thyroxine (26.24±4.04) pmoL/L was significantly higher than that in the control group (16.88±3.52) pmoL/L, the difference was statistically significant (P<0.05). After 12 months, the diameter of small nodules and TSH of the female patients in the observation group were (4.32±1.76) mm and (0.31±0.10) mIU/L, respectively, which were significantly lower than those of the male patients (5.62±1.76) mm and (0.46±0.15) mIU/L, and the difference was statistically significant (P<0.05). FT4 was (29.61±5.42) pmoL/L, which was significantly higher than (21.26±4.37) pmoL/L in men, and the difference was statistically significant (P<0.05). The diameter of small nodules and TSH of patients <45 years old were (4.94±1.26) mm and (0.34±0.13) mIU/L, respectively, and the values of (5.86±1.58) mm and (0.49±0.15) mIU/L of patients ≥45 years old were significantly reduced (P<0.05). FT4 was (28.81±3.07) pmoL/L, which was significantly lower than that of male (22.60±4.00), and the difference was statistically significant (P<0.05). Conclusion: Low-dose l-t4 can effectively control the thyroid benign small nodule biochemical index to inhibit the secretion of TSH and increase the FT4 level and control the growth of benign small nodules. It is more effective for female patients and patients <45 years old.
|
|
|
|
|
[1] 刘义粉,尹长恒,郑保恒,等.小剂量左甲状腺素治疗甲状腺良性小结节的效果及影响因素分析[J].河北医科大学学报,2017,38(5):607~610. [2] de Almeida Jacqueline Fátima Martins,Ward Laura Sterian. Thyroid autoimmune diseases and thyroid tumors: Would EBV infection be the link[J]. Journal of Cellular Physiology,2019,234(11):19141~19142. [3] 邓晓辉,高福兰,杨艳丽,等.温阳解毒消瘿方和小剂量左甲状腺素片联用对高碘地区结节性甲状腺肿患者的疗效影响[J].安徽医药,2018,22(11):2223~2226. [4] 张永文,张晓立,梅海云,等.甲状腺结节诊疗规范探讨[J].湖南中医药大学学报,2017,37(6):659~663. [5] 张丽波,张波,曹京,等.超微血管成像技术在TI-RADS4类甲状腺结节检测中的应用价值[J].中华超声影像学杂志,2017,26(12):1029~1033. [6] Lindsey Richard C,Godwin Catrina,Mohan Subburaman. Skeletal effects of nongenomic thyroid hormone receptor beta signaling.[J]. The Journal of Endocrinology,2019,242(3):173~183. [7] 沙雨蒙,王兴田,王荣.声脉冲辐射力成像鉴别诊断桥本甲状腺炎背景下甲状腺实性小结节良恶性[J].中国介入影像与治疗学,2017,14(8):504~508. [8] 毛艳玲,杨进,何芳,等.不同妊娠期亚临床甲状腺功能减退症孕妇血红蛋白水平与促甲状腺激素的相关性研究[J].中华内分泌代谢杂志,2018,34(6):505~508. [9] 刘彬彬,相萍萍,陈国芳,等.TI-RADS诊断甲状腺良、恶性结节的价值[J].江苏医药,2017,43(17):1260~1263. [10] 高福兰,王世飚,杨艳丽,等.小剂量左甲状腺素钠片联合瘿瘤消散汤治疗结节性甲状腺肿临床随机对照研究[J].现代中西医结合杂志,2018,27(24):47~48,51. |
|
|
|